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Abstract
Purpose The purpose of this study was to assess the psycho-
metric properties of a Swedish version of the Posttraumatic
Diagnostic Scale (PDS); to investigate the prevalence of trau-
matic experiences, trauma types, and posttraumatic stress dis-
order (PTSD) in a sample of patients seeking treatment for
chronic pain; and to examine how indices of pain-related func-
tioning vary with a history of traumatic exposure and PTSD
diagnostic status.
Method Participants were 463 consecutive patients with
chronic pain referred for assessment at the Pain
Rehabilitation Unit at Skåne University Hospital.
Results The translated version of the PDS demonstrated high
levels of internal consistency and a factor structure similar to
that reported in previous validation studies using samples
identified because of trauma exposure (not chronic pain), both
of which provide preliminary support for the validity of this
translated version. Based on their responses to the PDS, most
patients (71.8%) reported one or more traumatic events with
28.9% fulfilling criteria for a current PTSD diagnosis. The
patients with PTSD also reported significantly higher levels
of pain interference, kinesiophobia, anxiety, and depression
and significantly lower levels of life control, compared to
patients exposed to trauma and not fulfilling criteria for
PTSD and patients with no history of traumatic exposure.
Conclusion Consistent with previous research, a significant
proportion of patients seeking treatment for chronic pain re-
ported a history of traumatic exposure and nearly one third of
these met current criteria for PTSD according to a standard-
ized self-report measure. The presence of PTSD was associ-
ated with multiple indictors of poorer functioning and greater
treatment need and provides further evidence that routine
screening of chronic pain patients for PTSD is warranted.
Self-report measures like the PDS appear to be valid for use
in chronic pain samples and offer a relative low-cost method
for screening for PTSD.
Keywords Chronic pain . Posttraumatic stress disorder .
Pain-related functioning . The posttraumatic diagnostic scale
Introduction
Chronic pain is often defined as any pain that lasts more than
3 months [1], and chronic pain of moderate to severe intensity
occurs in 19% of adults in Europe [2]. Individuals presenting
for treatment of chronic pain often suffer from a range of
comorbid conditions, including but not limited to anxiety
and depression [3–5]. One such condition, underinvestigated
in this population, is posttraumatic stress disorder (PTSD),
which is defined by the presence of intrusions, avoidance,
negative alterations in cognitions and mood, and hyperarousal
and reactivity tied to the experience of a traumatic event [6].
The prevalence of PTSD in the general population has been
estimated at approximately 6.8% lifetime and 3.5% in any 12-
month period [7, 8]. People seeking treatment for chronic pain
experience PTSD at much higher rates with estimates ranging
from 9.5 to 45.3% [9–12]. Variability in PTSD prevalence in
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pain samples reflects differences in sample size (and methods
of ascertainment) and the PTSD criteria used for diagnosis
[10]. Likewise, high rates of chronic pain have been reported
in individuals identified because of PTSD, where research
mainly has been carried out with veteran samples [13–15].
Chronic pain patients with PTSD have been found to score
more highly on measures of emotional distress, pain intensity,
and pain disability compared to those with traumatic exposure
without PTSD and those without traumatic exposure [16]. The
presence of PTSD in chronic pain samples is associated with a
more severe presentation including higher levels of self-reported
physical health problems [13], kinesiophobia [17], pain intensity
[16, 18–21], pain-related disability [16, 19, 20, 22], and emotion-
al distress [16, 18, 20, 22] and lower self-reported life control
[23]. All of these variables are known to impact the efficacy of
treatments for chronic pain [24–26]. Different models have been
developed to explain this relationship, and two influential models
are the shared vulnerability and mutual maintenance models [27,
28]. A review of these models is beyond the scope of this article.
Briefly, the high rate of comorbidity between PTSD and chronic
pain may reflect shared predisposing factors to develop both
conditions and/or interaction of the two conditions through var-
ious mechanisms to increase the severity and duration of both.
For example, pain symptoms may trigger frequent traumatic in-
trusions; anxious arousal and hypervigilance associated with
PTSDmay heighten the person’s perception of pain and promote
avoidance of pain-related situations. However, the relationship
between PTSD and pain-related functioning in samples of pa-
tients seeking treatment for chronic pain remains
underinvestigated [21]. Undiagnosed symptoms of PTSD in peo-
ple seeking treatment for chronic pain may negatively impact
their prognosis, and it is to be expected that clinicians will be
required to adjust their treatment protocols to optimize treatment
effects for this group. Thus, it has been argued that individuals
seeking treatment for chronic pain should be routinely screened
for PTSD [28]. Self-report measures can be an inexpensive first
step in PTSD screening, and a large number of measures are
available, however few have been adequately validated in chron-
ic pain samples. The self-report Posttraumatic Diagnostic Scale
(PDS) developed by Foa and colleagues [29] is among the most
widely used measures of PTSD. The PDS is a comprehensive
measure assessing the history of trauma (including the event that
is/was most distressing), all of the DSM-IV symptoms of PTSD
aswell as their severity, the duration of symptoms, and associated
impairment. The psychometric properties of the PDS have been
fully reported [30–36] but not yet on a Swedish language version
of the scale.
The aims of this study are threefold. The first aim is to
assess the psychometric properties of a Swedish version of
the PDS. First, we investigate whether the PDS possesses
acceptable internal consistency and construct validity. To as-
sess the latter, we examine the correlations between the PDS
and measures assessing convergent constructs. For reasons
relating to measurement burden on a clinical group, another
trauma/PTSD measure was not administered. Instead, we ex-
amine the relationship between scores on the PDS and mea-
sures of anxiety, depression, and kinesiophobia (fear of move-
ment that might exacerbate pain), which are used as part of the
standard clinical assessment of adults seeking treatment for
chronic pain at the unit where the present data were collected.
Consistent with previous literature [29, 31, 34, 35, 37], and
given that the PTSD criteria include symptoms of arousal,
avoidance, fearful preoccupation, low mood, negative beliefs,
concentration difficulties, and sleep disturbance, we anticipate
moderately sized correlations between the PDS and measures
of anxiety, depression, and kinesiophobia.
As a further examination of the validity of this Swedish
translation of the PDS, we undertake confirmatory factor anal-
yses to assess the structural validity of the PDS. Several stud-
ies have investigated the factor structure of the symptom por-
tion (part 3) of the PDS and concluded that the observed
factors do not reliably correspond to the three symptom clus-
ters described in DSM-IV, i.e., re-experiencing, avoidance/
numbing, and hyperarousal [32, 36, 38]. In fact, evidence
from factor analytic investigations suggests that the three
symptom clusters from the DSM-IV may not conceptualize
PTSD symptoms in an optimal way [39]. Instead, the four-
factor models of emotional numbing [40] and dysphoria [41]
have gained empirical support along with other models. These
four-factor models influenced the most recent revision of the
DSM (5th edition), which now subdivides the PTSD symp-
toms into four clusters. Notably, the PTSD symptom criteria in
DSM-5 more closely resemble the four-factor structure as
suggested by the emotional numbing model [42, 43], i.e., re-
experiencing (factor 1), avoidance (factor 2), emotional numb-
ing (factor 3; similar to the negative cognitions and mood
factor from the DSM-5), and hyperarousal (factor 4; similar
to the alterations in arousal and reactivity factor from the
DSM-5). So in a partial test of the structural validity of this
Swedish translation of the PDS, we test whether the four-
factor emotion numbing model, comparable to the DSM-5
symptom clusters, better fits the data than the three-factor
solution corresponding to the DSM-IV PTSD criteria.
The second aim is to investigate the prevalence of traumat-
ic experiences, trauma types, and PTSD in a sample of pa-
tients seeking treatment for chronic pain. Based on previous
research [10, 16], we anticipated that ≥60% would report a
history of traumatic exposure and ≥20% would report symp-
toms consistent with a diagnosis of PTSD. The third aim is to
examine how indices of pain-related functioning vary with a
history of traumatic exposure and PTSD diagnostic status, as
assessed by the PDS. Differences in clinical characteristics
between three groups of patients with chronic pain are ex-
plored: those fulfilling criteria for PTSD, those exposed to
trauma and not fulfilling criteria for PTSD, and those not
exposed to trauma. Based on previous research [13, 16–23]
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and informed by the mutual maintenance model [27], we an-
ticipated that indices of pain, mental health, and general health
would all show greater dysfunction in the PTSD group versus
the other groups and that there would be no differences be-
tween the trauma-exposed group with no PTSD and the group
with no history of traumatic exposure.
Materials and Methods
Participants
Participants were 463 adults with chronic pain consecutively
referred for assessment at the Pain Rehabilitation Unit at
Skåne University between August 2013 and February 2015.
This government-funded unit based within Swedish national
health services is the largest specialist center for the assess-
ment and treatment of chronic pain in Region Skåne, the
southernmost region of Sweden with 1.26 million inhabitants
(approximately 13% of the total Swedish population). All pa-
tients gave written informed consent prior to their data being
used in the study, and the study was approved by the Regional
Ethical Review Board (2013/381).
The sample consisted of 334 women (72.1%) and 129 men
(27.9%) between 18 and 67 years of age (M = 41.1 years;
SD = 11.3). The majority (77.4%) were born in Sweden or
another Nordic country, and approximately half (53.3%) were
currently in work or further education. More than half had
upper secondary school as their highest level of education
(54.4%), with 14.2% having completed secondary school
and 27.1% having studied at or completed university. The
median timesincepainonsetwas5.0years (range=29.3years),
and the median number of pain locations was 13.0 (range = 36
locations). Usual pain intensity rated on a 0–10 scale was 7.5
(SD = 1.5). The most frequently reported primary diagnoses
were fibromyalgia (28.4%), cervicocranial syndrome (9.6%),
cervicobrachial syndrome (8.7%), lumbago (8.7%), and my-
algia (7.0%). The sociodemographic and clinical characteris-
tics of this sample were similar to the clinic’s referrals as a
whole and to patients seeking treatment for chronic pain at
other regional specialist pain units across Sweden [44].
Translation of the PDS
Internationally recommended guidelines were followed when
translating the PDS for the purposes of this study [45]. First, a
translation was made by a Swedish clinical psychologist who
was fluent in English and with detailed knowledge of the
research field. Second, the PDS was back-translated into
English by a Swedish psychologist who was also fluent in
English and with experience of instrument translation and
validation. Third, the translated and back-translated versions
of the PDS were reviewed by an expert group working in the
field of pain rehabilitation with specific knowledge of PTSD
and fluent in both Swedish and English. Changes and updates
were made according to suggestions of the expert group. The
updated version of the PDS was then administered to a group
of patients from the pain clinic to identify any needed changes
to improve clarity and comprehensibility of the instructions
and items, and then a final version was agreed by the expert
group.
Measures
Prior to the first face-to-face assessment at the chronic pain
unit, a range of self-report measures (described below) were
sent to the patients’ homes to be completed and brought to
their first full clinical assessment (functioning, suitability
for treatment, and diagnosis). At the same time, the patients
also provided information relating to age, gender, educa-
tion, country of birth, work status, pain sites, and pain
duration.
The Posttraumatic Diagnostic Scale The PDS is a 49-item
self-report measure of current PTSD symptoms related to a
single identified traumatic event. It assesses all of the diagnos-
tic criteria (A–F) for PTSD in DSM-IV and is composed of
four parts. Part 1 is a trauma checklist including serious acci-
dent, natural disaster, non-sexual assault by someone you
know, non-sexual assault by a stranger, sexual assault by
someone you know, sexual assault by a stranger, combat, sex-
ual contact when young with someone 5 years older, impris-
onment, torture, life-threatening disease, and Bother^ traumat-
ic event (not captured by the categories). Part 2 asks the re-
spondents to identify their most upsetting traumatic event,
when it happened, if anyone was injured, if they perceived
life threat, and whether the event resulted in helplessness or
terror. Part 3 measures the severity of the 17 symptoms listed
under categories B (intrusive recollections), C (avoidance/
numbing), and D (hyperarousal) in DSM-IV. Part 4 measures
interference from these 17 symptoms. A total severity score
(ranging from 0 to 51) is calculated based on the 17 symptoms
in part 3 (1–10 = mild; 11–20 = moderate; 21–35 = moderate
to severe; ≥36 = severe). The original scale has been found to
possess excellent internal consistency (α = .92), satisfactory
test-retest coefficients (range = .77 to .85), and good conver-
gent validity in relation to PTSD diagnosis assessed by stan-
dardized clinical interview. The scale has also demonstrated
satisfactory relationships with measures of anxiety and de-
pression [29]. The reliability and validity of a translated
Swedish version were tested in this study.
Hospital Anxiety and Depression Scale The HADS is a 14-
item self-report measure designed to identify symptoms of
anxiety and depression (separately) among patients in a med-
ical setting. The anxiety and depression subscales each
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contain seven items rated on a four-point scale (0 to 3) with
higher scores indicating greater severity. Consistent with the
original [46], the Swedish version used in this study has ex-
cellent internal reliability for the total (α = .90), anxiety
(α = .84), and depression scales (α = .82). It also correlates
significantly with alternative measures of anxiety and depres-
sion [47].
The Medical Outcomes 36-Item Study Short Form Health
Survey The 36-Item Study Short Form Health Survey
(SF-36) is a 36-item self-report measure of non-disease-
specific health and functioning widely used in health re-
search. It is composed of 8 subscales, but only physical func-
tioning (10 items) and general health (5 items) were used in
this study. Scores on the subscales are transformed to a 0–100
scale with higher scores indicating a greater health state.
Consistent with the English language original [48], the
Swedish version used in this study has been shown to have
satisfactory internal reliability for the subscales (α = .79 to
.91) and clinical validity when compared with other measures
of health functioning [49].
Multidimensional Pain Inventory (Version 2) The
Multidimensional Pain Inventory (MPI, version 2) is a 61-
item measure of pain-related functioning. Items are broken
down into three sections, each composed of its own subscales.
Only two subscales of the first section were used in this study:
pain interference (11 items) and life control (4 items). Items
are rated on a 7-point scale (0 = never; 6 = very often) [50].
The original MPI has satisfactory psychometric properties
(α = .70 to .90) [51], and the Swedish version used in this
study correlates significantly with other measures of pain-
related functioning and is sensitive to the effects of treatment
targeting chronic pain [24, 52].
Numerical Rating Scale The Numerical Rating Scale (NRS)
is the most widely used measure of pain intensity in both
research and clinical settings. It is composed of a single item
wherein the patient rates the intensity of their pain over the
past week on a scale ranging from 0 (no pain) to 10 (worst
possible pain). The NRS is commonly used in pain clinics and
research and been shown to be a valid and sensitive measure
of pain intensity [53, 54].
Tampa Scale of Kinesiophobia The Tampa Scale of
Kinesiophobia (TSK) is a 17-item self-report measure of fear
of movement or (re)injury. Items are rated on a 4-point scale
(1 = strongly disagree; 4 = strongly agree) with higher scores
indicating greater fear of movement/(re)injury. The TSK, in-
cluding the Swedish version used in this study, has been
shown to have satisfactory psychometric properties (α = .67
to .76) [37, 55, 56] and to correlate significantly with
measures of pain-related functioning and with measures of
anxiety and depression [37, 56, 57].
Statistical Approach
Psychometric Analyses
The internal consistency and reliability of the PDS were ex-
amined via inter-item correlations, item-total correlations, and
Cronbach’s alpha. Item-total correlations above r = .30 and a
Cronbach’s alpha above .70 were considered acceptable [58].
Construct validity was assessed via pairwise Pearson correla-
tions between the PDS, total score and total scores on each of
the subscales, total scores on the anxiety and depression sub-
scales of the HADS, and total score on the TSK. Correlations
between the PDS, total score and total scores on each of the
subscales, and relevant clinical variables (pain duration, num-
ber of pain locations, pain intensity, pain interference, life
control, physical functioning, and general health) were also
investigated. Correlation coefficients were evaluated as small
(.1–.3), moderate (.3–.5), or strong (.5–1.0) [59].
Confirmatory factor analyses were undertaken using max-
imum likelihood estimation procedures with goodness of fit
evaluated by the relative/normed chi-square statistic (χ2/df;
acceptable fit <5) [60], the root mean square error of approx-
imation (RMSEA; close fit <.05, reasonable fit <.08, and me-
diocre fit <.10) [61], and the comparative fit index (CFI; ade-
quate fit >.90, good fit >.95) [60, 62]. The relative/normed
chi-square (χ2/df) was used instead of the traditional chi-
square value together with the associated p value because it
reduces the likelihood of falsely rejecting the model when one
uses large sample sizes as was done here [60]. Item loadings
were investigated, and standardized regression weights above
.32 were considered acceptable [63]. The sample size of the
study was deemed satisfactory according to established guide-
lines [64, 65].
Descriptive Analyses
The prevalence of trauma, trauma type, and a current PTSD
diagnosis were examined. Next, a multivariate analysis of
variance (MANOVA) was conducted to test whether a linear
combination of clinical characteristics (pain duration, number
of pain locations, pain intensity, pain interference, life control,
physical functioning, general health, anxiety, depression, and
kinesiophobia) differed between three subgroups of chronic
pain patients: group 1 = those fulfilling criteria for PTSD;
group 2 = those exposed to trauma and not fulfilling PTSD
criteria; and group 3 = those with no history of traumatic
exposure. Patients were divided into these groups using all
the DSM-IV criteria for PTSD (A to F) as measured by the
self-report measure PDS. Univariate analyses of variance
(ANOVAs) on each of the dependent variables or clinical
Int.J. Behav. Med.
characteristics were conducted as follow-up tests to the
MANOVA. Post hoc analyses were performed to examine
mean differences across the three groups on all clinical char-
acteristics. Bonferroni-corrected p values were used to test for
significance to reduce the likelihood of type I error [66]. All
analyses were carried out using SPSS and AMOS (Version
22).
Results
Attrition Analyses
Of the 463 patients included in the study, a total of 24 (5%)
had enough missing items on the PDS such that it was not
possible to determine if they currently met the DSM-IV
criteria for PTSD, and they were excluded from all further
analyses. For the remaining 439 patients included in the
descriptive analyses, percentage of missing data for clinical
variables was very low (range = 0 to 4.8%) and Little’s
MCAR test was non-significant (chi-square = 79.3, df = 87,
p = .71), indicating that the data were missing at random.
For the purposes of validating the PDS, only the 315 pa-
tients who reported a traumatic event on part 1 of the PDS
were used in the analyses. For this subsample of trauma-
exposed patients, the percentage of missing data was again
very low (range = 0 to 4.8%), and Little’s MCAR test was
non-significant (chi-square = 654.5, df = 625, p = .201),
indicating that the data were missing at random.
Consequently, it was deemed acceptable to use data from
all patients and to impute missing values using the
expectation-maximization (EM) method [67]. Visual inspec-
tion of histograms, normal Q-Q plots, and boxplots ensured
that items were approximately normally distributed. Minor
non-normality was seen among the items from the PDS but
with all absolute values of skewness ≤1.4 and kurtosis ≤1.6.
Maximum likelihood (ML) estimation is robust with respect
to minor non-normality, skewness levels below 3 and kurto-
sis levels below 10 [68]. Therefore, ML estimation was used
in the confirmatory factor analyses. Outliers (n = 21) were
identified by computing standardized scores using absolute z
values larger than 3 as a cutoff. The affected values of the
outliers were winsorized and included in all analyses [69].
Psychometric Analyses
Item Analyses
The response rates were above 95.6% for all 17 symptom
severity items. All items correlated with each other at an ac-
ceptable level (r = .20 to .73), and item-total correlations were
consistently .30 analyzing all symptom severity items togeth-
er (range = .45 to .71). Cronbach alphas for the total score
(based on symptom items only) was high (α = .92). The
Cronbach alphas for the items comprising the three-factor
model (corresponding to DSM-IV criteria) were as follows:
factor 1 (re-experiencing), α = .89; factor 2 (avoidance/
numbing), α = .85; and factor 3 (hyperarousal), α = .82.
Cronbach alphas for the emotional numbing four-factor model
(similar to DSM-5 PTSD criteria) were as follows; factor 1
(re-experiencing), α = .89; factor 2 (avoidance), α = .72;
factor 3 (emotional numbing), α = .82; and factor 4 (hyper-
arousal), α = .82. The mean total score on the PDS was 15.58
(SD = 11.72) for the entire sample and 25.36 (SD = 9.61) for
patients who met criteria for a current diagnosis of PTSD,
corresponding to the moderate to severe range of symptom
severity. The mean total score for patients who reported a
trauma but did not meet current PTSD criteria was 8.97
(SD = 7.71), corresponding to the mild range of symptom
severity.
Validity
Correlations between PDS total score (symptom severity) and
total scores on each of the three factor-derived subscales
ranged from r = .60 to.86, and correlations between the
PDS total score and total scores on each of the four factor-
derived subscales ranged from r = .51 to .87 (all p < .001).
Table 1 presents correlations between the PDS, total score
and the total scores on the three factor-derived subscales,
and convergent construct as well as clinical variables. In line
with expectations, positive correlations in the moderate range
were found between the PDS and anxiety, depression, and
kinesiophobia. Small correlations were seen between the
PDS and number of pain locations, pain intensity, pain inter-
ference, life control, physical functioning, and general health.
Taken together, the results indicate acceptable construct va-
lidity of the PDS.
Fit indices from the confirmatory factor analyses are
displayed in Table 2. The three-factor model based on the
DSM-IV symptom criteria displayed an unfavorable fit
(second column of Table 2), with mostly non-satisfactory values
(RMSEA and CFI). The standardized factor loadings varied
from .48 to .81. The four-factor emotional numbing model
displayed a mixture of both satisfactory (CFI and χ2/df) and
unsatisfactory fit values (RMSEA) (third column of Table 2).
The standardized factor loadings varied from .45 to .83.
Modification indices from the emotional numbing model indi-
cated a high level of covariance between item 37 (BBeing overly
alert (for example checking to see who is around you, being
uncomfortable with your back to a door, etc.)) and item 38
(BBeing jumpy or easily startled (for example when someone
walks up behind you^)). To investigate if model fit could be
improved, one complementary model was tested, where the er-
ror terms of these itemswere allowed to covary. This adjustment
was considered appropriate since both items targeted
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hypervigilance and loaded on the same factor. Permitting this
covariance improved the four-factor model fit and all values fell
in the target range (last column of Table 2), and the standardized
factor loadings varied from .44 to.83.
Descriptive Analyses
Prevalence of PTSD and Primary Traumatic Events
Out of 439 patients in the study, 315 (71.8%) reported
experiencing at least one previous trauma(s). Of these
trauma-exposed patients, a total of 127 fulfilled DSM-IV
criteria (A–F) for PTSD based on their responses to the PDS
(group 1 in Table 3). Thus, of the 439 patients referred for
assessment of chronic pain, 28.9% fulfilled criteria for a PTSD
diagnosis. A total of 188 trauma-exposed patients did not
report sufficient symptoms on the PDS to fulfill DSM-IV
criteria for a diagnosis of PTSD (group 2 in Table 3). For
patients reporting a history of traumatic exposure (groups 1
and 2), no significant differences were observed for the types
of traumas reported. When the patients were asked to identify
their most upsetting traumatic event, the most frequently re-
ported traumas were Bother^ traumatic event (27.9%) follow-
ed by serious accident (23.8%), life-threatening illness (8.3%),
sexual assault by someone you know (7.6%), sexual assault
by a stranger (4.4%), and non-sexual assault by a stranger
(4.1%). Additionally, 14.6% of the patients were unable to
identify their most upsetting traumatic event and instead re-
ported multiple traumas. Finally, 124 of the 463 patients did
not report a traumatic experience (group 3 in Table 3) and so
no PTSD scores were calculated. Significant differences on
sex or age were not seen among the three groups.
Group Differences
A MANOVAwas conducted to test the hypothesis that there
would be significant mean differences between three groups
of patients: group 1 = those fulfilling criteria for PTSD, group
2 = those exposed to trauma and not fulfilling PTSD criteria,
and group 3 = those with no history of traumatic exposure, on
a combination of their clinical characteristics measured prior
to face-to-face assessment and treatment. A statistically sig-
nificant effect was obtained (Wilk’s = .82; F (20,854) = 4.36;
p < .001), with 9% of the variance in the canonically derived
dependent variable accounted for by group membership. This
significant MANOVA was followed by a series of ANOVAs
for each of the dependent variables using Bonferroni-adjusted
alphas (see Table 3). With the exception of pain duration,
significant differences were observed between the three
groups for number of pain sites, pain intensity, pain interfer-
ence, life control, physical functioning, general health,
Table 2 Fit indices for three- and four-factor models of the PDS
Model DSM-IV
three-factor
model
Emotional
numbing
four-factor
model
Emotional
numbing
four-factor model
with modifications
χ2/df 4.17 3.39 2.53
RMSEA
(confidence
interval)
.10
(.09–.11)
.09
(.08–.10)
.07 (.06–.08)
CFI .87 .91 .94
Notes: Goodness-of-fit indices were the relative/normed chi-square sta-
tistic (χ2 /df; acceptable fit <5), the root mean square error of approxima-
tion (RMSEA; close fit <.05, reasonable fit <.08, and mediocre fit <.10),
and the comparative fit index (CFI; adequate fit >.90, good fit >.95)
Table 1 Correlations between
the PDS and clinical variables PDS total Re-experiencing Avoidance/numbing Hyperarousal
Pain duration −.05 −.04 −.05 −.01
Number of pain sites .10 .13* .04 .12*
Pain intensity .20** .20** .17** .17**
Pain interference .28** .22** .32** .23**
Life control −.32** −.29** −.30** −.29**
Physical functioning −.22** −.22** −.19** −.16**
General health −.23** −.22** −.19** −.20**
Anxiety .49** .47** .41** .42**
Depression .40** .34** .42** .36**
Kinesiophobia .38** .27** .36** .32**
Notes: Similar correlations were obtained using the four symptom clusters from the emotional numbing model.
Pain intensity was assessed with the Numerical Rating Scale, pain interference and life control with the
Multidimensional Pain Inventory, physical functioning and general health with the Medical Outcomes Study
Short Form 36-Item Health Survey, anxiety and depression with the Hospital Anxiety and Depression Scale,
and kinesiophobia with the Tampa Scale of Kinesiophobia
*p < .05; **p < .01
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anxiety, depression, and kinesiophobia (all p ≤ .05). Post hoc
comparisons using Bonferroni-adjusted alpha indicated that
group 1 had significantly higher levels of pain interference,
kinesiophobia, anxiety, and depression and a significantly
lower level of life control when compared with groups 2
and 3. Furthermore, group 1 had significantly higher pain
intensity and lower physical functioning compared to group
2 as well as worse general health and more pain sites com-
pared to group 3. Consistent with expectations, no significant
differences on any of the variables were found between
groups 2 and 3.
Discussion
The first aim of this study was to assess the psychometric
properties of a Swedish version of the Posttraumatic
Diagnostic Scale (PDS). Overall, this Swedish language ver-
sion of the PDS demonstrated high levels of internal consis-
tency and reliability as well as acceptable construct validity.
Likewise, and in accordance with previous studies of the fac-
torial validity of the PDS in samples selected because of ex-
posure to trauma and not chronic pain, the three-factor solu-
tion based on the PTSD symptom clusters in the DSM-IV did
not provide an optimal fit to the data [35, 36, 39]. Instead, a
better fit was obtained with a four-factor solution consistent
with the emotional numbing model [40], which is similar to
the PTSD symptoms clusters as now defined in DSM-5 [42,
43]. Hence, the results from this study support the bifurcation
of the original avoidance/numbing criterion in DSM-IV and
the resulting clustering of symptoms into four separate criteria
in DSM-5. Research within this field is ongoing, and other
models, such as the five-factor dysphoric arousal model sep-
arating the hyperarousal symptoms into two categories, have
been proposed and gained tentative empirical support [35, 42].
It is also important to note that proposals have been made to
revise the existing formulation of PTSD in the upcoming ICD-
11, removing all symptoms non-specific to PTSD leaving on-
ly re-experiencing, avoidance, and perception of heightened
current threat [70]. Hence, further studies are needed on the
clustering of PTSD symptoms. To our knowledge, this is the
first study to carry out a confirmatory factor analysis of the
PDS in a chronic pain sample. Our findings overall suggest
that the measure performs similarly in chronic pain patients as
it does in samples selected for traumatic exposure or because
they were seeking treatment for PTSD. While further valida-
tion is possible particularly employing structured diagnostic
interviews for PTSD, the present findings suggest that the
PDS is a reliable and sound measure that is able to yield valid
inferences regarding PTSD in chronic pain samples.
The second aim of this study was to investigate the preva-
lence of traumatic experiences, trauma types, and posttraumat-
ic stress disorder (PTSD) in a sample of patients seeking treat-
ment for chronic pain. Consistent with our hypotheses and
previous studies of people with chronic pain [9–12, 16], we
found high rates of traumatic exposure (71.8%) and of PTSD
(28.9%). These findings for the prevalence of PTSD are in line
with those (23%) reported in another study based in
Table 3 Differences in clinical
characteristics between patients
fulfilling criteria for PTSD (group
1), trauma-exposed patients not
fulfilling criteria for PTSD (group
2), and non-trauma exposed
patients (group 3)
Variable F M (sd) Mean differences
Group 1
(n = 127)
Group 2
(n = 188)
Group 3
(n = 124)
1 vs 2 1 vs 3 2 vs
3
Pain duration .22 7.24 (7.32) 7.74 (7.32) 7.78 (7.50) −.50 −.54 −.04
Number of pain
sites
3.61* 15.93 (9.14) 15.24 (9.02) 13.08 (8.28) .68 2.85* 2.16
Pain intensity 3.59* 7.67 (1.56) 7.24 (1.54) 7.56 (1.39) .43* .11 −.33
Pain
interference
9.19** 5.00 (.88) 4.59 (.91) 4.59 (.94) .41** .41** −.00
Life control 12.61** 1.89 (1.05) 2.47 (1.14) 2.47 (1.05) −.58** −.57** .01
Physical
functioning
4.73** 42.53 (24.03) 50.20 (21.25) 48.71 (21.88) −7.67** −6.17 1.50
General health 3.82* 32.62 (17.18) 37.60 (18.95) 38.42 (18.92) −4.99 −5.80* −.82
Anxiety 33.49** 13.46 (4.38) 9.66 (4.52) 9.40 (4.71) 3.80** 4.06** .26
Depression 17.75** 11.81 (4.40) 9.14 (4.43) 8.92 (4.40) 2.67** 2.89** .22
Kinesiophobia 13.32** 46.16 (9.21) 41.08 (9.02) 41.55 (8.92) 5.08** 4.61** −.47
Notes: All alpha levels were adjusted using the Bonferroni correction. Degrees of freedom were df1 = 2 and
df2 = 436. Pain duration wasmeasured in years. Pain intensity was assessedwith the Numerical Rating Scale, pain
interference and life control with the Multidimensional Pain Inventory, physical functioning and general health
with the Medical Outcomes Study 36-Item Short Form Health Survey, anxiety and depression with the Hospital
Anxiety and Depression Scale, and kinesiophobia with the Tampa Scale of Kinesiophobia
*p < .05; **p < .01
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Scandinavia and focused on people with chronic pain [10]. In
agreement with earlier research, Bother^ traumatic events, se-
rious accidents, life-threatening disease, sexual and non-
sexual assault, and multiple traumas were frequently reported
traumas in this study [10, 12].
The final aim of the study was to examine how indices of
pain-related functioning vary with a history of traumatic ex-
posure and PTSD diagnostic status as assessed by the PDS.
Understanding the association between PTSD and chronic
pain has been identified as an important focus of research with
implications for the treatment of both conditions [28]. The
results from this study add to a growing body of literature
which suggests that presence of PTSD symptoms may exac-
erbate the effects of chronic pain. This study was not designed
to test mutual maintenance, nevertheless our findingsmight be
interpreted as providing some support for such a model [27].
We found that fear of movements that might exacerbate pain
(kinesiophobia) and interference from pain were elevated in
the PTSD group relative to the groups without PTSD, whether
they reported a history of traumatic exposure or not. It is
possible that the heightened physiological arousal and hyper-
vigilance to harm that characterize PTSD exacerbate the fear
of movements associated with pain and that the avoidance of
such movements is related to the greater disability and inter-
ference found in the chronic pain group with PTSD. We note
however that the overall level of pain intensity was very mar-
ginally elevated and only when compared to the trauma-
exposed patients without PTSD and not the non-exposed
group. These findings contrast to some extent with the notion
that PTSDmay heighten one’s perception of pain as suggested
in the mutual maintenance model [27] and with previous stud-
ies where the presence of PTSD was associated with higher
pain intensity in chronic pain groups [16, 18–21]. The number
of pain sites was elevated in the PTSD group relative to the
non-exposed group, and no differences were observed be-
tween the PTSD and the two comparison groups for pain
duration. Previous studies have not identified a relationship
between PTSD and pain duration or the number of pain sites
in chronic pain samples [16, 23]. Overall, the current findings
point to a much clearer relationship between the presence of
PTSD and certain aspects of the pain experience, i.e., the fear
of movements that might trigger pain and interference from
pain, rather than the duration, distribution, or intensity of pain.
In line with our hypothesis, patients with chronic pain and
PTSD in this study had much poorer clinical presentations
than those without PTSD. Specifically, patients with chronic
pain fulfilling criteria for PTSD reported significantly higher
levels of anxiety and depression and significantly lower levels
of life control compared to the other groups. Furthermore,
patients with PTSD reported lower levels of physical function-
ing compared to the trauma-exposed patients without PTSD
and worse general health than the non-trauma exposed group.
Overall, this study provides support for the view that PTSD
symptoms interact with those of chronic pain. The direction of
causality and which specific aspects of the pain experience
that interact with PTSD remains somewhat unclear and re-
quires further investigation including longitudinal designs.
We did not expect there to be, nor did we find marked differ-
ences in clinical characteristics between patients with chronic
pain who had been exposed to a trauma and did not meet
criteria for PTSD and those with no history of traumatic
exposure.
It is important to note that scores on the measure of
anxiety and depression were elevated in the PTSD group
compared to both comparison groups. This is consistent
with previous findings [16, 22] but raises the issues of
whether the exacerbation effects of PTSD on certain as-
pects of chronic pain arise from the cluster of symptoms
unique to PTSD (i.e., intrusive recollections) or from
symptoms overlapping with those of anxiety and depres-
sion, two conditions which are common in chronic pain
patients [3–5]. In other words, any comorbid problem of
mood and anxiety is likely to exacerbate pain-specific
impairments, and the associations observed here may not
be specific to the presence of PTSD. To address this ques-
tion, correlations between pain-related measures and
scores on the PDS re-experiencing, avoidance/numbing,
and hyperarousal subscales, displayed in Table 1, can be
used. Our results suggest that the correlations with pain-
related functioning are equally strong among all PTSD
symptom clusters. Hence, symptom clusters unique to
PTSD (i.e. re-experiencing) seem to play a role in the
relationship with pain-related functioning.
Current psychological treatments for chronic pain produce
small to medium effect sizes, and chronic pain researchers
have begun to try to identify the particular components of
psychological treatments (or mechanisms) which work for
different patients and to try to understand why [26, 71].
While further research is needed, the results of the present
study suggest that the very modest effect sizes obtained for
psychological treatment of pain may be due partly to the pres-
ence in this population of undiagnosed and untreated condi-
tions like PTSD, whose presence may negatively influence
treatments aimed at chronic pain. Considering the high prev-
alence of comorbid PTSD and chronic pain in specialized care
research on the issue is limited. Within the PTSD literature, a
few studies have examined whether empirically supported
treatments are effective in treating comorbid PTSD and chron-
ic pain. Lesser efforts have been made to investigate whether
traditional pain treatments are effective in treating comorbid
PTSD and chronic pain [72]. Hence, such studies are needed
to address this comorbidity and identify components of psy-
chological treatments used to target chronic pain that may be
effective in reducing the adverse impacts of PTSD and im-
proving pain-related functioning. In addition to this, studies
with chronic pain patients receiving both psychological
Int.J. Behav. Med.
treatment for chronic pain and PTSD are needed to investigate
whether concurrent or prior treatment for PTSD improves
outcomes.
Findings from the present study must be viewed within the
context of certain limitations. It was not possible to investigate
all relevant psychometrics in this study as the standard assess-
ment protocol of the clinic from where this sample was drawn
does not include structured clinical interviews or other self-
report measures of PTSD. Hence, future studies are needed to
further assess the construct validity of this Swedish translation
of the PDS and complement the analyses with other reliability
and validity indicators. The Swedish version of the Numerical
Rating Scale for pain intensity has not been formally validated
but is used throughout Sweden with chronic pain patients and
shows high correlations with other pain-related measures [44].
Also, the sample was composed of chronic pain patients, the
majority of whom were women with relatively high levels of
education, and thus, the results may not generalize to non-
clinical samples, to other groups of patients who have been
exposed to a trauma but are seeking treatment for some other
condition, or to more diverse samples generally. There was
relatively little missing data in the current study, and the data
were missing at random. Nevertheless, our analyses included
patients who had missing data on one or more of the studied
variables and missing values were imputed using the
expectation-maximization (EM) method. The Posttraumatic
Diagnostic Scale for DSM-5 did not exist when data collection
for this study started. Still, with the new DSM-5 and the up-
coming ICD-11 diagnostic classifications for PTSD, the as-
sessment of the DSM-IV version of the PDS can be seen as a
limitation. The groups used in the analyses were divided based
on a self-report questionnaire, and the participants had not
been clinically diagnosed with PTSD. Still, the PDS has dem-
onstrated high diagnostic agreement with clinical interviews
for PTSD [29]. In addition to this, we lack information as to
whether the index trauma for the PTSD also was the cause of
the patient’s chronic pain. Finally, it is important to point out
that people who are traumatically exposed but do not fulfill the
diagnostic criteria for PTSD may still have symptoms of
PTSD that are highly distressing or debilitating and informa-
tion may be lost by looking at PTSD by using a binary vari-
able (i.e., fulfilling criteria or not). Our analyses suggested that
the chronic pain patients who reported exposure to a trauma
but who did not report sufficient symptoms to meet criteria for
PTSD had PTSD symptoms only in the mild range. However,
in the absence of structured diagnostic interviews, it is not
possible to say with certainty that all of the patients in this
group did not currently meet diagnostic criteria.
In conclusion, this study supports the reliability and valid-
ity of this Swedish language version of the PDS. Consistent
with previous research, a significant proportion of patients
seeking treatment for chronic pain reported a history of trau-
matic exposure and nearly one third of these met current
criteria for PTSD according to a standardized self-report mea-
sure. Patients with chronic pain and comorbid PTSD had
much poorer clinical presentations than the trauma-exposed
group without PTSD and the non-trauma-exposed group.
The presence of PTSD was associated with multiple indictors
of poorer functioning and greater treatment need and provides
further evidence that routine screening of chronic pain patients
for PTSD is warranted. Self-report measures like the PDS
appear to be valid for use in chronic pain samples and offer
a relative low-cost method for screening for PTSD.
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